MAN1A2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.006600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.257000E-01
Normal-vs-Stage2
8.252000E-01
Normal-vs-Stage3
1.298960E-01
Normal-vs-Stage4
3.609600E-01
Stage1-vs-Stage2
8.642200E-01
Stage1-vs-Stage3
1.259980E-01
Stage1-vs-Stage4
1.970780E-01
Stage2-vs-Stage3
1.681370E-01
Stage2-vs-Stage4
4.215800E-02
Stage3-vs-Stage4
9.096300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.513000E-01
Normal-vs-AfricanAmerican
4.475800E-01
Normal-vs-Asian
3.773000E-01
Caucasian-vs-AfricanAmerican
3.744200E-02
Caucasian-vs-Asian
3.655000E-01
AfricanAmerican-vs-Asian
3.573600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.510000E-01
Normal-vs-Female
8.771800E-01
Male-vs-Female
5.331400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.865000E-01
Normal-vs-Age(41-60Yrs)
8.429600E-01
Normal-vs-Age(61-80Yrs)
6.556600E-01
Normal-vs-Age(81-100Yrs)
1.978840E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.942600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.382600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.277400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.277800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.561500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.599380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.348400E-01
Normal-vs-Daily Drinker
2.405400E-01
Normal-vs-Weekly Drinker
3.923400E-01
Normal-vs-Occasional Drinker
8.529200E-01
Normal-vs-Social Drinker
9.341800E-01
Non Drinker-vs-Daily Drinker
6.238400E-01
Non Drinker-vs-Weekly Drinker
8.211000E-01
Non Drinker-vs-Occasional Drinker
7.074500E-02
Non Drinker-vs-Social Drinker
1.840370E-01
Daily Drinker-vs-Weekly Drinker
5.760800E-01
Daily Drinker-vs-Occasional Drinker
4.783800E-02
Daily Drinker-vs-Social Drinker
1.335000E-01
Weekly Drinker-vs-Occasional Drinker
1.258370E-01
Weekly Drinker-vs-Social Drinker
2.538800E-01
Occasional Drinker-vs-Social Drinker
8.798000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.187000E-01
Normal-vs-Grade 2
1.188390E-01
Normal-vs-Grade 3
9.623700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.655400E-01
Grade 1-vs-Grade 3
4.940200E-01
Grade 1-vs-Grade 4
2.187000E-01
Grade 2-vs-Grade 3
9.929800E-01
Grade 2-vs-Grade 4
1.188390E-01
Grade 3-vs-Grade 4
9.623700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.640400E-01
Normal-vs-NonDiabetic
6.485400E-01
Diabetic-vs-NonDiabetic
8.527600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.496000E-01
Normal-vs-NoPancreatitis
7.138200E-01
Pancreatitis-vs-NoPancreatitis
1.954050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.027800E-01
Normal-vs-N1
8.713200E-01
N0-vs-N1
4.429200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.041600E-01
Normal-vs-TP53-NonMutant
9.200600E-01
TP53-Mutant-vs-TP53-NonMutant
4.558400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
